Vaccination is the most effective strategy to prevent influenza virus infection and its serious complications. However, influenza viruses are prone to mutation, and the dominant strains vary by year. Each year, vaccine manufacturers develop and produce influenza vaccines based on the strains recommended by WHO.

Sino Biological offers comprehensive solutions for influenza vaccine development and production to vaccine manufacturers. They provide a wide range of influenza virus research reagents, including influenza vaccine antigens, antibody pairs, neutralizing antibodies, and kits. Additionally, they offer high-quality technical services such as kit development, antigen expression, and antibody development. These products and services are suitable for various vaccine development scenarios, such as candidate vaccine strain screening, virus seed batch preparation, vaccine safety and immunogenicity assessment, and vaccine protective efficacy evaluation.

Visit Sino Biological or click on the Request Information button below to send an email.